Showing results (611-620 of 929) with videos related to
Sort By:
Pageof 93
Journal of Psychosomatic Research|July 31, 2007
Pain in depression: STAR*D study findingsMustafa M Husain, A John Rush, Madhukar H Trivedi, et al.Psychosomatics|March 25, 2010
Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorderAmy Farabaugh, Joseph J Locascio, Liang Yap, et al.The Journal of Clinical Psychiatry|December 14, 2022
Rapidity of Symptom Improvement With Intranasal Esketamine for Major Depressive Disorder: A Systematic Review and Meta-AnalysisRebecca S Hock, Anna Feeney, Nadia Iovieno, et al.Depression and Anxiety|March 11, 2006
The combination of duloxetine and bupropion for treatment-resistant major depressive disorderGeorge I Papakostas, John J Worthington, Dan V Iosifescu, et al.Asian Journal of Psychiatry|November 18, 2017
Outcomes of an online computerized cognitive behavioral treatment program for treating chinese patients with depression: A pilot studyAlbert Yeung, Fang Wang, Fan Feng, et al.The Journal of Clinical Psychiatry|February 20, 2003
Nortriptyline for treatment-resistant depressionAndrew A Nierenberg, George I Papakostas, Timothy Petersen, et al.Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|May 9, 2015
Similar changes in cognitions following cognitive-behavioral therapy or escitalopram for major depressive disorder: Implications for mechanisms of changeAmy Farabaugh, Lauren Fisher, Maren Nyer, et al.Annals of General Psychiatry|March 2, 2010
Residual sleep disturbance and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetineHuaiyu Yang, Lara Sinicropi-Yao, Sarah Chuzi, et al.Depression and Anxiety|April 22, 2009
Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trialEdward S Friedman, Stephen R Wisniewski, William Gilmer, et al.Journal of Clinical Psychopharmacology|July 14, 2009
Metabolic assessment of aripiprazole as adjunctive therapy in major depressive disorder: a pooled analysis of 2 studiesMaurizio Fava, Stephen R Wisniewski, Michael E Thase, et al.Pageof 93